Novartis to buy U.S.-based biotech firm Excellergy for up to $2 billion
March 27 (Reuters) – Swiss drugmaker Novartis said on Friday it will buy California-based biotech company Excellergy in a deal…
Tag: Excellergy
Novartis to Acquire Excellergy in Deal Worth Up to $2 Billion
Novartis AG reached an agreement to pay as much as $2 billion to acquire biotech firm Excellergy Inc. www.bloomberg.com #Novartis…